We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 98 → 0 (-98)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $504M → $0 (-$504M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 98

Holders
–
Holders Change
-98
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
98
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AAM
Alpine Associates Management
Florida
-$37.5M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$28.2M
3
TAL
TIG Advisors LLC
New York
-$27.1M
4
WIC
Water Island Capital
New York
-$26.3M
5
MF
Magnetar Financial
Illinois
-$23.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
76
Virtu KCG Holdings
New York
– -$318K -15,208 Closed
AIG
77
American International Group
New York
– -$317K -15,159 Closed
Wells Fargo
78
Wells Fargo
California
– -$283K -13,499 Closed
BA
79
BlackRock Advisors
Delaware
– -$282K -13,479 Closed
HLA
80
Hamilton Lane Advisors
Pennsylvania
– -$264K -12,636 Closed
WAM
81
Wolverine Asset Management
Illinois
– -$257K -12,300 Closed
VOYA Investment Management
82
VOYA Investment Management
Georgia
– -$253 -12,101 Closed
Citigroup
83
Citigroup
New York
– -$248K -11,825 Closed
CSS
84
Cubist Systematic Strategies
Connecticut
– -$217K -10,396 Closed
ST
85
Sphinx Trading
Illinois
– -$167K -8,000 Closed
Royal Bank of Canada
86
Royal Bank of Canada
Ontario, Canada
– -$136K -6,500 Closed
UBS Group
87
UBS Group
Switzerland
– -$94K -4,533 Closed
Legal & General Group
88
Legal & General Group
United Kingdom
– -$94K -4,500 Closed
CPA
89
Cowen Prime Advisors
New York
– -$88K -4,200 Closed
BlackRock
90
BlackRock
New York
– -$52K -2,484 Closed
FNYS
91
First New York Securities
New York
– -$51K -2,437 Closed
MLICM
92
Metropolitan Life Insurance Company (MetLife)
New York
– -$48K -2,303 Closed
BNP Paribas Financial Markets
93
BNP Paribas Financial Markets
France
– -$39.3K -1,878 Closed
Bank of America
94
Bank of America
North Carolina
– -$31K -1,497 Closed
CG
95
Cutler Group
California
– -$23K -1,100 Closed
TRCT
96
Tower Research Capital (TRC)
New York
– -$15K -726 Closed
PHK
97
Point72 Hong Kong
Hong Kong
– -$13K -600 Closed
Creative Planning
98
Creative Planning
Kansas
– -$12K -563 Closed
1 2 3
4

VTAE Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q4 2016, worth a combined $0 — down 100% from $504M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of VTAE and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Alpine Associates Management, exiting entirely with an estimated $37.5M sold.

  • 0 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q4 2016, down from 98 in Q3 2016.
  • Funds reported $0 of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q4 2016 and 98 closed out, a net change of -98 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q4 2016 was Alpine Associates Management, an estimated $37.5M sold.

Based on aggregated 13F filings for Q4 2016.